Pan-histone deacetylase (HDAC) inhibitors have been used to increase histone acetylation, however, while these can cause cancer cell death in cells with very high histone acetylation levels, this may also cause an undesired conversion of non-MICs to MICs. The gene discussed is HDAC9; the disease is cancer.